General Electric (GE) PT Raised To $13 At Barclays After BioPharma Divestiture

March 4, 2019 6:54 AM EST Send to a Friend
Barclays analyst, Julian Mitchell, reiterated his Overweight rating on shares of General Electric (NYSE: GE) and raised his price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login